X
Power Law company profile
XtalPi
Biotech & Life Sciences · Shenzhen, China · Founded 2014 · IPO 2024 Unicorn
Valuation
$2.75B
Market cap · 2026
Revenue
$37M
Latest reported FY
Global footprint
Where XtalPi has talent and traffic
AI talent share
1.0%
of workforce is AI talent
(3 of 305 staff)
(3 of 305 staff)
Core AI30.98%
Other AI00%
Non-AI workforce30299.02%
Web traffic by country
39K
monthly visits
across markets
across markets
🇨🇳 China47.7%
🇺🇸 United States17.7%
🇮🇳 India11.3%
🇭🇰 Hong Kong6.4%
🇬🇧 United Kingdom5.9%
Patent intelligence
$100k patent portfolio · 2 active families
Total estimated portfolio value via Dealroom Patent Intelligence (Patsnap), with quality scores compared against same-sector peers.
Estimated portfolio value
$100k
<0.01% of market cap · 424.3× smaller than top peer Evotec ($42M)
2 active patent families
Where XtalPi innovates
Molecular biologyStimulator of interferon genesPhosphoinositide 3-kinaseCarcinosisKinase
Above peer median on Legal, Economic, Technology
Quality vs same-sector peers
XtalPi on the five Patsnap quality dimensions
XtalPi in orange. Same-sector peers are the top filers by total patent value. All scores 0–100; higher is stronger.
Compare against
Patent quality scores (0–100)
Source: Dealroom Patent Intelligence · PatsnapTech-focus vs peers
Where XtalPi concentrates inside the peer cluster
Axes are the most-shared Patsnap topics across XtalPi and its top peers. Each polygon's reach on an axis = how prominent that topic is in that company's portfolio (#1 topic = 100, #10 = 10, absent = 0).
Compare against
Top-topic prominence (rank inverted, 0–100)
Source: Dealroom Patent Intelligence · Patsnap top-10 topics per companySee XtalPi on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.